Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,733 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,059 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00477841 | Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer | completed | Phase 2 | 60 | Southeast University, ChinaOTHER | 1 | Apr 18, 2008 | clinicaltrials |
| NCT00261092 | GEMOX: Oxaliplatin in Pancreatic Cancer | completed | Phase 2 | 48 | SanofiINDUSTRY | 1 | Apr 15, 2008 | clinicaltrials |
| NCT00635323 |
| Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma |
| completed |
| Phase 2 |
| 73 |
| PfizerINDUSTRY |
| 4 |
| Apr 7, 2008 |
| clinicaltrials |
| NCT00087503 | Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy | completed | Phase 2 | 28 | PfizerINDUSTRY | 5 | Apr 1, 2008 | clinicaltrials |
| NCT00001428 | A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001805 | A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00005926 | Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00051987 | Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma | completed | Phase 2 | 175 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00590278 | A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer(TOMUDEX) | completed | Phase 2 | 49 | AstraZenecaINDUSTRY | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00082082 | A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma | completed | Phase 2 | — | SciClone PharmaceuticalsINDUSTRY | 1 | Jan 15, 2008 | clinicaltrials |
| NCT00591045 | Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer | unknown | Phase 2 | 263 | Peking UniversityOTHER | 1 | Jan 11, 2008 | clinicaltrials |
| NCT00176787 | Radiation Therapy With Capecitabine in Rectal Cancer | terminated | Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00580359 | S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer | unknown | Phase 2 | 96 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 8, 2008 | clinicaltrials |
| NCT00515190 | Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma | unknown | Phase 2 | 198 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00587145 | Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer | unknown | Phase 2 | 44 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00286000 | High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study | completed | Phase 2 | 106 | University Hospital, GhentOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00116506 | Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 35 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00123825 | Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer | completed | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00165217 | Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma | completed | Phase 2 | 37 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00234429 | A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma | completed | Phase 2 / Phase 3 | 74 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00464295 | Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)(HCC-CAP) | completed | Phase 2 | 15 | Aga Khan UniversityOTHER | 1 | Dec 14, 2007 | clinicaltrials |
| NCT00122876 | Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 25 | Light Sciences OncologyINDUSTRY | 3 | Dec 7, 2007 | clinicaltrials |
| NCT00073138 | A Study of ABT-751 in Patients With Colorectal Cancer | completed | Phase 2 | 40 | AbbottINDUSTRY | 1 | Nov 29, 2007 | clinicaltrials |
| NCT00081627 | Clinical Trial in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 48 | Mast Therapeutics, Inc.INDUSTRY | 2 | Nov 27, 2007 | clinicaltrials |
| NCT00191412 | A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver | completed | Phase 2 | 41 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2007 | clinicaltrials |
| NCT00120172 | Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer | terminated | Phase 2 | 40 | Geriatric Oncology ConsortiumOTHER | 1 | Nov 16, 2007 | clinicaltrials |
| NCT00557713 | XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma | unknown | Phase 2 | 44 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socialsOTHER | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00079872 | Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer | completed | Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 5 | Nov 6, 2007 | clinicaltrials |
| NCT00536770 | A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer | suspended | Phase 2 | 132 | NovaceaINDUSTRY | 1 | Nov 6, 2007 | clinicaltrials |
| NCT00385021 | ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | 20 | Southwestern Regional Medical CenterOTHER | 1 | Nov 2, 2007 | clinicaltrials |
| NCT00209651 | Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer | unknown | Phase 2 | 40 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00209677 | Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer | suspended | Phase 1 / Phase 2 | 40 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00436423 | A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer | completed | Phase 2 | 38 | Korea University Anam HospitalOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00352833 | Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma | completed | Phase 2 | 40 | Neovii BiotechINDUSTRY | 1 | Oct 26, 2007 | clinicaltrials |
| NCT00191568 | Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer | completed | Phase 2 | 45 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 19, 2007 | clinicaltrials |
| NCT00337545 | Phase II Trial of RAD001 in Refractory Colorectal Cancer | completed | Phase 2 | 22 | Swedish Medical CenterOTHER | 1 | Oct 10, 2007 | clinicaltrials |
| NCT00536614 | Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer(SPaCe-01) | completed | Phase 2 | 86 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Sep 28, 2007 | clinicaltrials |
| NCT00534664 | Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma(TheraBionic) | completed | Phase 1 / Phase 2 | 40 | University of Sao PauloOTHER | 1 | Sep 26, 2007 | clinicaltrials |
| NCT00154804 | CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Aug 23, 2007 | clinicaltrials |
| NCT00294359 | The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer | completed | Phase 2 / Phase 3 | 333 | Australasian Gastro-Intestinal Trials GroupNETWORK | 2 | Aug 22, 2007 | clinicaltrials |
| NCT00514930 | Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the Liver | unknown | Phase 1 / Phase 2 | — | University of ThessalyOTHER | 1 | Aug 10, 2007 | clinicaltrials |
| NCT00509964 | Second-Line Irinotecan vs. ILF for AGC | unknown | Phase 2 | 50 | Gachon University Gil Medical CenterOTHER | 1 | Aug 1, 2007 | clinicaltrials |
| NCT00510107 | Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC | unknown | Phase 2 | 90 | Gachon University Gil Medical CenterOTHER | 1 | Aug 1, 2007 | clinicaltrials |
| NCT00154778 | Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer | completed | Phase 2 | 55 | National Taiwan University HospitalOTHER | 1 | Jul 31, 2007 | clinicaltrials |
| NCT00506168 | Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer | terminated | Phase 2 | 37 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00506571 | Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer(TIROX2) | unknown | Phase 2 | 42 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00506623 | Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer | unknown | Phase 2 | 48 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 25, 2007 | clinicaltrials |
Data updated 23 days agoSource updated Apr 18, 2008source: clinicaltrials